Last update :
27/11/2024
Immunosuppressant   Adalimumab  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Abrilada Argentina
Amgevita Belgium, Chile, France, Germany, Great Britain
Hadlima Australia
Hulio Germany
Humira Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Denmark, Ecuador, Finland, France, Germany, Great Britain, Greece, Iceland, Italy, Japan, Mexico, Netherlands, New Zealand, Norway, Peru, Poland, Portugal, Romania, Saudi Arabia, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, United States of America, Venezuela
Hyrimoz Brazil, Ecuador, Slovenia
Imraldi Belgium, Great Britain, Slovenia, Spain
Truxeda Austria, Belgium, Denmark, Finland, Germany, Greece, Iceland, Japan, Poland, Sweden
References   injection   References : Adalimumab  
Type Publication
4627 Journal Park D, Yun J, Hwang S-J, Park SJ.
Evaluation of Physicochemical and Biological Stability of 36-Months-Aged SB5 (Adalimumab Biosimilar) for 4 Weeks at Room Temperature.
Adv Ther 2019 36:442–450
4644 Journal Kyeong Shin Y, Yong Han W, Jung Kim S, Woo Kim K, Won Ro J, Bin Lee J, Seok Oh J, Astier A.
Investigation of the Physicochemical and Biological Stability of the Adalimumab Biosimilar CT-P17.
Adv Ther 2021 ; 38 : 5609–5622

  Mentions Légales